ID   UKRV-Mel-06a
AC   CVCL_A704
SY   UKRV-Mel-6a; UKRV-Mel-6
DR   BTO; BTO_0005347
DR   ESTDAB; ESTDAB-111
DR   Wikidata; Q54990561
RX   PubMed=7646526;
RX   PubMed=10594685;
RX   PubMed=15592718;
CC   HLA typing: A*02:01,01:01; B*15:01:01:01,40:01; C*03:04,03:03; DPB1*04:01,03:01; DQB1*06:04,03:02; DRB1*04:01,13:02 (PubMed=15592718).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-111
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 12,13
ST   FGA: 23
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A705 ! UKRV-Mel-06b
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
RX   PubMed=7646526; DOI=10.1006/bbrc.1995.2187;
RA   Artuc M., Nurnberg W., Czarnetzki B.M., Schadendorf D.;
RT   "Characterization of gene regulatory elements for selective gene
RT   expression in human melanoma cells.";
RL   Biochem. Biophys. Res. Commun. 213:699-705(1995).
//
RX   PubMed=10594685; DOI=10.1046/j.1365-2567.1999.00902.x; PMCID=PMC2326956;
RA   Sun Y.-S., Moller P., Berking C., Schlupen E.-M., Volkenandt M.,
RA   Schadendorf D.;
RT   "In vivo selective expansion of a tumour-specific cytotoxic T-cell
RT   clone derived from peripheral blood of a melanoma patient after
RT   vaccination with gene-modified autologous tumour cells.";
RL   Immunology 98:535-540(1999).
//
RX   PubMed=15592718; DOI=10.1007/s00262-004-0561-5; PMCID=PMC11032966;
RA   Rodriguez T., Mendez R., Roberts C.H., Ruiz-Cabello Osuna F., Dodi I.A.,
RA   Lopez-Nevot M.A., Paco L., Maleno I., Marsh S.G.E., Pawelec G.,
RA   Garrido F.;
RT   "High frequency of homozygosity of the HLA region in melanoma cell
RT   lines reveals a pattern compatible with extensive loss of
RT   heterozygosity.";
RL   Cancer Immunol. Immunother. 54:141-148(2005).
//